
Noubar Afeyan
American-Canadian entrepreneur, inventor, and philanthropist
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian billionaire businessman, inventor, and philanthropist. He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.2
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
Born Jul 25, 1962.1
About
As of November 2021, his net worth is estimated at $3.3 billion. He was awarded the National Medal of Technology and Innovation in 2025.
From Wikipedia’s article on Noubar Afeyan, shared under CC BY-SA 4.0.2
Companies
- Generate Biomedicines, Inc.Board member Feb 26, 2026 to now10
- Foghorn Therapeutics Inc.Board member Jan 15, 2026 to now11
- ModernaBoard member 2012 to now12
- Flagship PioneeringFounder13
- Omega Therapeutics, Inc.Board member Jul 29, 2021 to Jun 9, 202314
- Rubius Therapeutics (United States)Board member Jul 17, 2018 to May 13, 202215
- Seres Therapeutics, Inc.Board member Jun 25, 2015 to Jun 20, 201916
- Evelo Biosciences, Inc.Board member May 8, 2018 to Jun 13, 201917
- Kaleido Biosciences, Inc.Board member Feb 27, 2019 to Mar 6, 201918
- Selecta Biosciences (United States)Board member Jun 21, 2016 to Jun 21, 201619
- Carisma Therapeutics Inc.Board member Feb 5, 2014 to Mar 24, 201420
- AgenusBoard member Jan 17, 2006 to Jun 11, 200721
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Moderna MRNA2,971,912 shares22$673.6M at $226.67May 22, 2026- Seres Therapeutics, Inc. MCRB376,018 shares23$925.0K at $2.46Jul 7, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2026Sold 9,263 shares at $46.84 of Moderna22
- May 21, 2026Exercised options 9,263 shares at $19.15 of Moderna22
- Dec 11, 2025Sold 23,853 shares at $29.49 of Moderna24
- Dec 11, 2025Exercised options 23,853 shares at $10.90 of Moderna24
- Jul 31, 2024Sold 1,309 shares at $121.62 of Moderna25
- Jul 31, 2024Sold 3,428 shares at $120.88 of Moderna25
- Jul 31, 2024Sold 5,664 shares at $119.84 of Moderna25
- Jul 31, 2024Sold 4,599 shares at $118.96 of Moderna25
- Jul 24, 2024Sold 2,000 shares at $119.01 of Moderna26
- Jul 24, 2024Sold 6,832 shares at $118.30 of Moderna26
- Jul 24, 2024Sold 3,500 shares at $117.25 of Moderna26
- Jul 24, 2024Sold 2,668 shares at $116.33 of Moderna26
- Jul 17, 2024Sold 700 shares at $124.61 of Moderna27
- Jul 17, 2024Sold 6,699 shares at $123.82 of Moderna27
- Jul 17, 2024Sold 2,900 shares at $122.86 of Moderna27
- Jul 17, 2024Sold 2,100 shares at $121.57 of Moderna27
- Jul 17, 2024Sold 2,601 shares at $120.86 of Moderna27
- Jul 10, 2024Sold 500 shares at $119.95 of Moderna28
- Jul 10, 2024Sold 1,100 shares at $119.28 of Moderna28
- Jul 10, 2024Sold 3,000 shares at $117.83 of Moderna28
- Jul 10, 2024Sold 4,279 shares at $117.18 of Moderna28
- Jul 10, 2024Sold 6,121 shares at $116.01 of Moderna28
- Jun 26, 2024Sold 100 shares at $134.05 of Moderna29
- Jun 26, 2024Sold 700 shares at $131.56 of Moderna29
- Jun 26, 2024Sold 2,705 shares at $130.76 of Moderna29
Early life and education
Afeyan has authored numerous scientific papers. He has patented over 100 inventions. Between 2000 and 2016 he was a senior lecturer at the MIT Sloan School of Management and is currently (as of 2020) a lecturer at Harvard Business School.
In July 2022, Afeyan was conferred with an honorary doctorate degree from Yerevan State University.
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
Career
Occupation: entrepreneur, businessperson, inventor, donor.7
- Since 2012Board member, Moderna6
- Date not recordedFounded Flagship Pioneering4
- Date not recordedFounded Foundation for Armenian Science and Technology5
Afeyan was inspired by a meeting in 1985 with David Packard to become an entrepreneur. He started his first biotechnology company in 1987, just a few days before Black Monday, and founded or co-founded five more companies within ten years. By 2020 Afeyan had co-founded and developed 41 start-ups. In total, he co-founded or helped build over 50 life science and technology startups.
Afeyan is the founder and CEO of Flagship Pioneering, a venture capital company focused on biotechnology, in 2000. The firm has "fostered the development of more than 100 scientific ventures, resulting in $20 billion in total value and over 500 patents." According to the company website, Flagship Pioneering has "fostered the development of more than 100 scientific ventures resulting in $30 billion in aggregate value, thousands of patents and patent applications, and more than 50 drugs in clinical development."
In 2009 Afeyan co-founded Moderna (formerly ModeRNA Therapeutics) and currently serves as its chairman. He owns over 2 million shares in the company; in 2018, Moderna had the biggest IPO in the biotech industry's history.
In 2021, Afeyan announced that Moderna would not enforce its patent rights against anyone using those patents to make COVID-19 vaccines.
In 1988, he founded PerSeptive Biosystems and served as its CEO. The company's annual revenues grew to $100 million and in 1998 was acquired by PerkinElmer/Applera and became CBO of Applera. There he oversaw the creation of Celera Genomics.
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
Personal life
Afeyan was born to Armenian parents in Beirut, Lebanon in 1962. His grandfather survived the Armenian genocide. Talking about his background, Afeyan said: "One of the only unfortunate advantages Armenians have had by having gone through a genocide and having spread around the world is that we do have an experience of escaping and of immigrating and of constantly restarting." His family fled Lebanon in 1975, during the civil war there. He graduated from Loyola High School in Montreal in 1978. He received his B.Eng. in chemical engineering from McGill University in 1983 and then moved to the US and earned a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987. He was the first Ph.D. graduate from MIT's Center for Bioprocess Engineering, at the time the only institution with that degree program. He became a U.S. citizen in 2008.
Besides English, Afeyan speaks Western Armenian. Afeyan is married to Anna (born Gunnardottir), a Swedish-born engineer who moved to the US in 1988. They have four children, and currently reside in Lexington, Massachusetts.
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
Philanthropy
Afeyan sits on the boards of the MIT Corporation, the Boston Symphony Orchestra, and the Armenian General Benevolent Union (AGBU).
Afeyan has worked closely with other prominent Armenian diaspora philanthropists, most notably Ruben Vardanyan on projects related to Armenia. Afeyan had partnered with Vardanyan to establish Initiatives for Development of Armenia (IDeA), which according to the Armenian government, has between 2007 and 2017 implemented different projects with a total cost of $550 million. Earlier, in 2001 Afeyan, Vardanyan and others launched the "Armenia 2020" initiative, which aimed to identify development prospects for Armenia until 2020. It has since been expanded to 2031. In 2005 Afeyan and Vardanyan met with Armenian president Robert Kocharyan to present the key directions of the project.
In 2008 Afeyan, Vardanyan and others co-founded the National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the country. As a member of its board, he met with Armenian Prime Minister Tigran Sargsyan in 2009 and 2012.
With Vardanyan and Vartan Gregorian, Afeyan co-founded the Aurora Humanitarian Initiative in 2015. It includes The 100 Lives initiative, which celebrates survivors and rescuers of the Armenian genocide, and the Aurora Prize for Awakening Humanity, an annual award given to an individual (and an affiliated organization) who has faced personal risk to enable others to survive since 2016. In 2020 Armenian Prime Minister Nikol Pashinyan lauded Afeyan, Vardanyan and Gregorian for "glorifying humanity," and "materializ[ing] the noble idea of immortalizing the memory of the innocent victims of the Armenian Genocide."
Afeyan is a member of the board of UWC Dilijan International School in Armenia, founded by Vardanyan in 2014., a founding angel of Foundation for Armenian Science and Technology (FAST). and Future Armenian public initiative.
He points to his immigrant background and mentality as the driving forces of his philanthropic, scientific, and business work.
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
Politics
In October 2016 Afeyan joined other prominent Armenians on calling the government of Armenia to adopt "new development strategies based on inclusiveness and collective action" and to create "an opportunity for the Armenian world to pivot toward a future of prosperity, to transform the post-Soviet Armenian Republic into a vibrant, modern, secure, peaceful and progressive homeland for a global nation."
After the Velvet Revolution of 2018, Afeyan congratulated Nikol Pashinyan on being elected Armenia's prime minister and wrote that "With this turning point, we have an opportunity to bring together the skills and enthusiasm of Armenians across the globe who are able to contribute to accelerating Armenia’s and Artsakh’s growth and prosperity." In July 2021 Afeyan met with Pashinyan in Yerevan. In March and May 2020, Afeyan and Armenian president Armen Sarkissian discussed the COVID-19 pandemic.
During the 2020 Nagorno-Karabakh war, Afeyan wrote a letter to the editor of The New York Times in which he called for the US to step in and stop the war. "Whether or not the United States and Russia intervene to quell the violence has implications for vulnerable peoples around the world. When world powers step in to stop unfolding atrocities, it sends a signal to aggressors that annexing land or destroying a people and culture will not be tolerated," he wrote.
In November 2020, Afeyan confirmed that the Canadian government had been among the first countries to pre-order the Moderna vaccine; the country is guaranteed to get some portion of the first batch dispensed to the public.
In 2023, Noubar has called on US politicians and judges to stop questioning established science and over-ruling regulators.
From Wikipedia’s article on Noubar Afeyan (this version), CC BY-SA 4.0.
In the news
1 recent article from 1 outlet we read name Noubar Afeyan. We match the full name, and check the article also names one of their companies or that they are well known.
- Opinion | JD Vance claims foreign students are undercutting America. The opposite is true.MSNBC, left, Oct 9, 2026…Ever heard of a company called Moderna? It was founded by Noubar Afeyan, who came to MIT as an international Ph.D.
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataNoubar Afeyan on Wikidata
- 2WikipediaNoubar Afeyan on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12Wikidata and SEC EDGARModerna, Board member
- 13WikidataFlagship Pioneering, Founder
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARAgenus, Board member
- 22
- 23
- 24SEC EDGARForm 4 filed Dec 15, 2025
- 25SEC EDGARForm 4 filed Aug 2, 2024
- 26SEC EDGARForm 4 filed Jul 26, 2024
- 27SEC EDGARForm 4 filed Jul 19, 2024
- 28SEC EDGARForm 4 filed Jul 12, 2024
- 29SEC EDGARForm 4 filed Jun 28, 2024
- 30Wikimedia CommonsNoubar Afeyan photo by Aleksey Chalabyan, a.k.a Xelgen, CC BY-SA 4.0